Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023).
Article in Swiss Medical Weekly (April 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Combination of Empagliflozin and Liraglutide protects heart against isoproterenol-induced myocardial infarction in rats
Article in Pharmacia (February 2023)
Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
Article in Diabetes Therapy (January 2023)